JPWO2025009503A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2025009503A5 JPWO2025009503A5 JP2025515752A JP2025515752A JPWO2025009503A5 JP WO2025009503 A5 JPWO2025009503 A5 JP WO2025009503A5 JP 2025515752 A JP2025515752 A JP 2025515752A JP 2025515752 A JP2025515752 A JP 2025515752A JP WO2025009503 A5 JPWO2025009503 A5 JP WO2025009503A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- peptide
- salt
- cells
- acid residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023109588 | 2023-07-03 | ||
| JP2023109588 | 2023-07-03 | ||
| PCT/JP2024/023780 WO2025009503A1 (ja) | 2023-07-03 | 2024-07-01 | 細胞膜透過性を有するペプチドおよびそのスクリーニング方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2025009503A1 JPWO2025009503A1 (https=) | 2025-01-09 |
| JPWO2025009503A5 true JPWO2025009503A5 (https=) | 2025-06-10 |
| JP7723457B2 JP7723457B2 (ja) | 2025-08-14 |
Family
ID=94171533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025515752A Active JP7723457B2 (ja) | 2023-07-03 | 2024-07-01 | 細胞膜透過性を有するペプチドおよびそのスクリーニング方法 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP7723457B2 (https=) |
| WO (1) | WO2025009503A1 (https=) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005013073A (ja) * | 2003-06-25 | 2005-01-20 | Mitsubishi Pharma Corp | 輸送ポリペプチドのスクリーニング方法 |
| WO2006041194A1 (ja) * | 2004-10-15 | 2006-04-20 | Japan Science And Technology Agency | ｍＲＮＡ－ピューロマイシン－タンパク質連結体作製用リンカー |
| KR100859972B1 (ko) * | 2006-02-20 | 2008-09-25 | 이화여자대학교 산학협력단 | 막투과 단백질 도메인 펩타이드 |
| RU2548807C2 (ru) * | 2009-05-20 | 2015-04-20 | Торэй Индастриз, Инк. | Пептиды, проникающие в клетку |
| US10736941B2 (en) * | 2015-05-19 | 2020-08-11 | National University Corporation Kumamoto University | Cell membrane-permeating peptide |
| NL2016207B1 (en) * | 2016-02-02 | 2017-08-21 | Stichting Katholieke Univ | Selective cell penetrating peptides. |
| HUE067838T2 (hu) * | 2016-09-21 | 2024-11-28 | Amal Therapeutics Sa | Egy sejtpenetráló peptidet, egy multiepitópot és egy TLR peptidagonistát tartalmazó fúzió rák kezelésére |
| EP3597223A1 (en) | 2018-07-17 | 2020-01-22 | Centre National De La Recherche Scientifique | Peptides for use as cell-penetrating peptides |
| KR102588548B1 (ko) * | 2019-07-16 | 2023-10-16 | 주식회사 젠센 | 자가면역질환 및 염증성질환 펩타이드 치료제 |
| JP7578991B2 (ja) * | 2019-08-28 | 2024-11-07 | 国立研究開発法人理化学研究所 | 細胞膜透過性ベシクル |
| TW202306965A (zh) * | 2021-05-12 | 2023-02-16 | 哥本哈根大學 | Ｐｓｄ－９５抑制劑及其用途 |
-
2024
- 2024-07-01 JP JP2025515752A patent/JP7723457B2/ja active Active
- 2024-07-01 WO PCT/JP2024/023780 patent/WO2025009503A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| O'Donnell et al. | The architecture of EMC reveals a path for membrane protein insertion | |
| Tong et al. | Structural differences between a ras oncogene protein and the normal protein | |
| Nogales et al. | Erratum: Structure of the αβ tubulin dimer by electron crystallography | |
| CA2304254C (en) | Trimerising module | |
| Unterreitmeier et al. | Phenylalanine promotes interaction of transmembrane domains via GxxxG motifs | |
| US8859507B2 (en) | Protein complex for intracellular delivery and uses thereof | |
| JP2024520528A5 (https=) | ||
| JP2002532055A (ja) | 子宮内膜腫瘍組織からのヒト核酸配列 | |
| KR20030074789A (ko) | 감소된 면역원성을 갖는 개질된 인간 뇌유래 신경영양인자 (ｂｄｎｆ） | |
| JP2023504826A5 (https=) | ||
| KR20030074790A (ko) | 감소된 면역원성을 갖는 개질 인터루킨-1 수용체길항제(ｉｌ-1ｒａ) | |
| CN105524147B (zh) | 重组聚多肽及其应用 | |
| JPWO2025009503A5 (https=) | ||
| KR20030074788A (ko) | 감소된 면역원성을 갖는 개질 렙틴 | |
| JP2005528124A5 (https=) | ||
| JP2002505877A (ja) | 前立腺腫瘍組織由来のヒト核酸配列 | |
| KR20220007619A (ko) | 면역조절 조성물 및 방법 | |
| Rodriguez et al. | Optimization of physicochemical and pharmacological properties of peptide drugs by glycosylation | |
| KR20030082961A (ko) | 감소된 면역원성을 갖는 개질 프로타민 | |
| EP3158058B1 (en) | Fusion proteins and uses thereof | |
| JP2008505626A5 (https=) | ||
| WO2015055148A1 (zh) | Yap蛋白抑制多肽及其应用 | |
| KR20110136504A (ko) | Ｒａｇｅ 수용체 표적 펩타이드에 약물을 결합시킨 것을 특징으로 하는 약물 복합체 | |
| KR20030074791A (ko) | 감소된 면역원성을 갖는 개질 각질세포성장인자(ｋｇｆ) | |
| Ojima et al. | Synthesis of Enkephalin analogs via asymmetric hydrogenation of dehydropeptide building blocks |